Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Buy Barr (A.G.) (BAG) by Deutsche Bank
- Buy Glencore (GLEN) by HSBC
- Neutral Barclays (BARC) by Exane
- Outperform Standard Chartered (STAN) by Exane
- Neutral HSBC Holdings (HSBA) by Exane
- Hold Aston Martin Lagonda Global Holdings (AML) by Deutsche Bank
- Buy Polar Capital Holdings (POLR) by Deutsche Bank
- Buy Unilever (ULVR) by Bank of America
- Buy Reckitt Benckiser Group (RKT) by Bank of America
- Neutral Haleon (HLN) by Bank of America
- Underweight Berkeley Group Holdings (The) (BKG) by Morgan Stanley
- Equal Weight Barratt Redrow (BTRW) by Morgan Stanley
- Buy Intermediate Capital Group (ICG) by Citi
- Buy Bridgepoint Group (Reg S) (BPT) by Citi
- Neutral National Grid (NG.) by Goldman Sachs
- Neutral Weir Group (WEIR) by Goldman Sachs
- Overweight Rentokil Initial (RTO) by Barclays
- Overweight Prudential (PRU) by Barclays
- Overweight Baltic Classifieds Group (BCG) by Barclays
- Overweight Halma (HLMA) by Barclays
AstraZeneca (AZN) Share Price
Health Care Sector
NOTE: This is based on 1,264 open tips for AstraZeneca (AZN)
| Latest Bid : 14,974.00p | Latest Ask : 14,980.00p |
| High Today : 15,032.00p | Low Today : 14,960.00p |
| This Years High : 15,316.00p | This Years Low : 10,022.00p |
| Volume : 56,007 | MKT Cap : £232190M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
AstraZeneca (AZN) Overview
A world-leading pharmaceutical group, AstraZeneca was created in 1999 via the merger of Sweden's Astra and the UK's Zeneca, which had been demerged from chemicals group ICI in 1993. About half of its total sales are generated from the US, with over a third of revenues coming from its gastrointestinal treatments such as Prilosec (Losec) and Nexium.AstraZeneca (AZN) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Buy | Jefferies | Premium Only | 2026-04-10 12:01:00 10/04/2026 | -2.79% |
| Buy | Citi | Premium Only | 2026-04-10 07:42:00 10/04/2026 | -0.12% |
| Add | Simon Watkins | Premium Only | 2026-04-08 07:00:00 08/04/2026 | -2.35% |
| Buy | Jefferies | Premium Only | 2026-03-06 04:48:00 06/03/2026 | 0.44% |
| Buy | UBS | Premium Only | 2026-02-26 05:52:00 26/02/2026 | -1.12% |
AstraZeneca (AZN) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 14,974.00p | Latest Ask : 14,980.00p |
| High Today : 15,032.00p | Low Today : 14,960.00p |
| This Years High : 15,316.00p | This Years Low : 10,022.00p |
| Volume : 56,007 | MKT Cap : £232190M |
AstraZeneca Overview
A world-leading pharmaceutical group, AstraZeneca was created in 1999 via the merger of Sweden's Astra and the UK's Zeneca, which had been demerged from chemicals group ICI in 1993. About half of its total sales are generated from the US, with over a third of revenues coming from its gastrointestinal treatments such as Prilosec (Losec) and Nexium.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest AstraZeneca Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Buy | Jefferies | Premium Only | 2026-04-10 12:01:00 10/04/2026 | -2.79% |
| Buy | Citi | Premium Only | 2026-04-10 07:42:00 10/04/2026 | -0.12% |
| Add | Simon Watkins | Premium Only | 2026-04-08 07:00:00 08/04/2026 | -2.35% |
| Buy | Jefferies | Premium Only | 2026-03-06 04:48:00 06/03/2026 | 0.44% |
| Buy | UBS | Premium Only | 2026-02-26 05:52:00 26/02/2026 | -1.12% |